Enanta Pharmaceuticals
ENTA
#7451
Rank
HK$3.28 B
Marketcap
HK$113.66
Share price
3.62%
Change (1 day)
82.34%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total assets

Total assets on the balance sheet as of June 2025 : HK$2.34 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total assets are HK$2.34 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Enanta Pharmaceuticals - Total assets on balance sheet (from 2011 to 2025)

Total assets by year

Year Total assets Change
2024-09-30HK$2.92 B-19.12%
2023-09-30HK$3.62 B22.84%
2022-09-30HK$2.94 B-13.74%
2021-09-30HK$3.41 B-9.32%
2020-09-30HK$3.76 B-1.87%
2019-09-30HK$3.83 B18.4%
2018-09-30HK$3.24 B27.11%
2017-09-30HK$2.55 B16.93%
2016-09-30HK$2.18 B14.43%
2015-09-30HK$1.90 B57.99%
2014-09-30HK$1.20 B33.02%
2013-09-30HK$0.90 B124.31%
2012-09-30HK$0.40 B98.93%
2011-09-30HK$0.20 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
AbbVie
ABBV
HK$1.042 T 44,380.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$1.500 T 63,952.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$193.54 B 8,159.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$1.008 T 42,934.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$754.24 B 32,085.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$835.20 B 35,540.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland